masschallenge

PlusVitech has been selected for MassChallenge US Early Cohort 2023.

PlusVitech has been selected for MassChallenge US Early Cohort 2023. The MassChallenge US Early Stage accelerator is a 3-month mentorship-based programme that provides intensive support, guidance, tools and connectivity to the MassChallenge community to drive traction for startups. The programme is industry independent and focuses on supporting approximately 200 startups per cohort that range in…

Details

PlusVitech wins 1st Gold Award in AcexHealth program

The Sevillian company PlusVitech has been awarded with the 1st prize (Gold) of the AcexHealth program in the final competition (Investor Day) that took place last Thursday, February 2 in the building of the Foundation of the Health Technology Park (PTS) of Granada. The AcexHealth Investor Day brought together in the same place more than…

Details

Andalusian SME Excellence Awards

Caixabank and Grupo Joly reward an Andalusian business sector that has managed to perfectly manage the day to day in the midst of the health crisis caused by the coronavirus. Caixabank and Grupo Joly are once again presenting the Awards for Excellence in Andalusian SMEs. This year, its XI edition is marked by the health…

Details

Onda Cero “Andalucía Capital” Awards Ceremony

Our CEO Vicente Salinas receives the award on behalf of Plus Vitech. The Andalusian president has participated in the delivery in Seville of the ‘Andalusia Capital Awards’ of Onda Cero, where he pointed out that “despite the eleven months that we have been in the pandemic, the Andalusian productive sector has been able to reinvent…

Details

Sevillian firm PlusVitech launches a treatment against Covid-19

The PVT COVID treatment could be used immediately and globally, if approved. The Sevillian company PlusVitech has launched the PVT-COVID treatment, which could speed up the recovery of patients affected by coronavirus by up to 200%, based on a drug that is already available in hospital pharmacies. “The PVT-COVID treatment, considered by the European Commission…

Details